China News Service, Kunming, March 25 (Reporter Miao Chao) In recent years, the biotechnology drug industry focusing on vaccines has become the fastest growing field in the biopharmaceutical industry in Yunnan Province.
The recently released "14th Five-Year Plan for the Innovation and Development of the Biomedical Industry in Yunnan Province" clarifies that the vaccine biotechnology drug industry will remain a key development area in Yunnan Province in the next five years.
In the next five years, Yunnan Province will still need to work hard to improve the upstream and downstream industrial chains, enhance the research and development capabilities of new vaccines, accelerate the construction of a rapid response system for major infectious diseases, strengthen frontier basic research, and enrich product pipelines.
Relying on Kunming and Yuxi to build biotech drug industry bases focusing on vaccines, vigorously develop new biological vaccines, antibody drugs, biosimilar drugs, cell preparations, blood products such as albumin, coagulation factors, immunoglobulins, and other proteins, Research and development and production of new products of polypeptide and nucleic acid drugs.
Yunnan Province also encourages vaccine companies to build digital and intelligent production lines and improve the level of production technology.
Guide enterprises in the province to establish, acquire and merge R&D institutions at home and abroad, build a quality system, R&D system and production technology system in line with international standards, promote the international registration and WHO pre-certification of biological vaccine products, and build vaccine production that meets international quality standards Supply base and domestic leading monoclonal antibody drug industry base, increase open cooperation with South Asia, Southeast Asia and the Indian Ocean Rim, and develop markets in South Asia, Southeast Asia, Africa and Europe and the United States.
(over)